The ORP project supports Montgomery County Ohio’s goal to reduce recidivism by expanding and enhancing substance abuse treatment, related recovery and re-entry services, and producing better outcomes for offenders with substance abuse and co-occurring disorders who return to their families and community from incarceration.
The SARDI Program partners with the MonDay Community Correctional Institution and local substance abuse treatment providers to focus on addressing the health disparities associated with access and retention in substance abuse treatment programs for ex-offenders. ORP case managers work with ex-offenders at pre-and post-release and provide transitional services associated with entry into substance abuse treatment services after release from incarceration.
Assist returning citizens being released from MonDay by:
- Providing case management/support services once released.
- Providing substance abuse recovery assistance.
- Providing education on topics such as drug use, sexual health, life skills, and healthy relationships.
- Referring for additional services as needed.
- Providing transportation to appointments and community resources.
To accurately assess lifetime substance use history as well as substance use during the previous three-month period, the ORP program utilizes the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) as part of the screening tool. The ASSIST was developed for the World Health Organization (WHO) and asks questions about specific substances individually. If the consumer has ever used a particular substance, there are additional questions asked pertaining to that substance. Scoring and severity are calculated for each individual substance. Substance use history is extensive with this population.
When asked about lifetime use of various substances, nearly all consumers reported having used tobacco products, alcohol, and marijuana (97.0%). Additionally, more than two-thirds reported having used, cocaine, amphetamines, and opioids at some point in their lifetime. Of those with lifetime use, recent substance use (during the previous three-month period) is also extensive with over 85% of consumers using tobacco products daily about 62% having used amphetamines daily, nearly 45% having used opioids daily and 37% have used marijuana every day.
Weekly or monthly use of alcohol, marijuana, cocaine, sedatives, and hallucinogens are also regularly indicated. The stacked bar chart depicted above also provides additional information. The percentage of consumers reporting any use for alcohol and opioids is roughly the same at 56-60%. However, it was also reported that there were more daily users of opioids than those who use alcohol daily.
The Patient Health Questionnaire (PHQ-9) is the most common screening tool to identify depression. Scores can range from 0-27 and consist of six categories: none (0), minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27). While at baseline the majority of consumers did not show any signs of depression, over a third (39.4%) displayed minimal symptoms and 9.1% showed either mild or moderate signs of depression.
The Satisfaction with Life Scale (SWLS) is a 5-item instrument designed to measure cognitive judgments of satisfaction with one’s life. Scores range from 5-35 and consist of seven categories: extremely dissatisfied (5-9), dissatisfied (10-14), slightly dissatisfied (15-19), neutral (20), slightly satisfied (21-25), satisfied (26-30), and extremely satisfied (31-35). Nearly half (42.4%) of consumers reported that they were generally satisfied with their life at baseline, 3% were neutral and the remaining majority (54.6%) ranged from slightly dissatisfied to extremely dissatisfied.
Jo Ann Ford